SK-OV-3
0 sources
SK-OV-3
Summary
SK-OV-3 is a cell line[1]. SK-OV-3 draws 19 Wikipedia views per month (cell_line category, ranking #24 of 37).[2]
Key Facts
- SK-OV-3's instance of is recorded as cell line[3].
- SK-OV-3's instance of is recorded as cancer cell line[4].
- SK-OV-3's described by source is recorded as One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23[5].
- SK-OV-3's described by source is recorded as Absence of HeLa cell contamination in 169 cell lines derived from human tumors[6].
- SK-OV-3's described by source is recorded as Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines[7].
- SK-OV-3's described by source is recorded as The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines[8].
- SK-OV-3's described by source is recorded as Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines[9].
- SK-OV-3's described by source is recorded as Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes[10].
- SK-OV-3's described by source is recorded as Human tumor lines for cancer research[11].
- SK-OV-3's described by source is recorded as Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies[12].
- SK-OV-3's described by source is recorded as Comparative properties of five human ovarian adenocarcinoma cell lines[13].
- SK-OV-3's described by source is recorded as Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies[14].
- SK-OV-3's described by source is recorded as Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.[15].
- SK-OV-3's described by source is recorded as Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines[16].
- SK-OV-3's described by source is recorded as Mutation of thePTENTumor Suppressor Gene Is Not a Feature of Ovarian Cancers[17].
- SK-OV-3's described by source is recorded as Systematic variation in gene expression patterns in human cancer cell lines[18].
- SK-OV-3's described by source is recorded as Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.[19].
- SK-OV-3's described by source is recorded as A Formalin-Fixed, Paraffin-Processed Cell Line Standard for Quality Control of Immunohistochemical Assay of HER-2/neu Expression in Breast Cancer[20].
- SK-OV-3's described by source is recorded as Multicolor spectral karyotyping of serous ovarian adenocarcinoma[21].
- SK-OV-3's described by source is recorded as CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential[22].
- SK-OV-3's described by source is recorded as Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers[23].
- SK-OV-3's described by source is recorded as Gene expression patterns in ovarian carcinomas[24].
- SK-OV-3's described by source is recorded as Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.[25].
- SK-OV-3's described by source is recorded as Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells[26].
- SK-OV-3's described by source is recorded as DNA fingerprinting of the NCI-60 cell line panel[27].
Why It Matters
SK-OV-3 draws 19 Wikipedia views per month (cell_line category, ranking #24 of 37).[2]